The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time-restricted eating and metformin (TEAM) in invasive breast cancer or DCIS: A randomized, phase IIb, window-of-opportunity presurgical trial.
 
Parijatham Thomas
No Relationships to Disclose
 
Stefano Spinaci
No Relationships to Disclose
 
Irene Maria Briata
No Relationships to Disclose
 
Mariangela Rutigliani
No Relationships to Disclose
 
Roberta Rizzo
No Relationships to Disclose
 
Giorgia Giancarli
No Relationships to Disclose
 
Davide Serrano
No Relationships to Disclose
 
Andrea Rattaro
No Relationships to Disclose
 
Monica Peresi
No Relationships to Disclose
 
Jessica Suarez-Colen
No Relationships to Disclose
 
Debora Macis
No Relationships to Disclose
 
Lana Vornik
No Relationships to Disclose
 
Araceli Garcia-Gonzalez
No Relationships to Disclose
 
Brandy Heckman-Stoddard
No Relationships to Disclose
 
Eileen Dimond
No Relationships to Disclose
 
Edward Sauter
No Relationships to Disclose
 
Saverio Minucci
No Relationships to Disclose
 
Bernardo Bonanni
Expert Testimony - Editree srl
 
Eduardo Vilar Sanchez
Consulting or Advisory Role - Abbvie; Janssen Research & Development; Moderna Therapeutics; Nouscom; Parabilis; Permanence Bio; Recursion Pharmaceuticals
Research Funding - Janssen Research & Development; Nouscom
Patents, Royalties, Other Intellectual Property - The University of Texas MD Anderson Cancer Center, Vilar E, Chang K, Wu W, Bowen CM, Sinha K. Methods and Compositions Comprising MHC Class I Peptides, United States, 63/171,137, 4/6/2021, Filed (Provisional); The University of Texas MD Anderson Cancer Center, Vilar E, Wu W, Katayama H, Hanash S, Bommi P. Methods for Prognosing, Diagnosing, and Treating Colorectal Cancer, United States, 63/152,751, 2/23/2021, Filed (Provisional)
 
Andrea De Censi
No Relationships to Disclose